X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (674) 674
index medicus (367) 367
female (294) 294
hereditary angioedema (279) 279
male (267) 267
immunology (250) 250
angioedema (227) 227
adult (198) 198
allergy (182) 182
bradykinin (172) 172
middle aged (172) 172
angioneurotic edema (168) 168
angioedema - genetics (155) 155
complement c1 inhibitor protein - metabolism (126) 126
animals (115) 115
c1 inhibitor (112) 112
bradykinin - metabolism (105) 105
aged (103) 103
angioedema - drug therapy (103) 103
complement c1 inactivator proteins - metabolism (97) 97
angioedema - diagnosis (94) 94
edema (93) 93
mutation (87) 87
adolescent (86) 86
allergy and immunology (81) 81
angioedemas, hereditary - drug therapy (75) 75
angioedema - etiology (74) 74
angioedemas, hereditary - diagnosis (74) 74
plasma (74) 74
complement c1 inhibitor protein (71) 71
angioneurotic-edema (69) 69
angioedema - immunology (68) 68
angioedema - metabolism (68) 68
c1 inhibitor deficiency (68) 68
child (67) 67
complement c1 inactivator proteins - genetics (65) 65
complement c1 inhibitor protein - genetics (65) 65
angioedema - blood (64) 64
management (64) 64
angioedema - therapy (63) 63
kallikrein (63) 63
angioedema - chemically induced (62) 62
medicine, general & internal (62) 62
diagnosis (59) 59
activation (58) 58
angiotensin-converting enzyme inhibitors - adverse effects (58) 58
molecular-weight kininogen (58) 58
enzymes (57) 57
c1-inhibitor (55) 55
young adult (55) 55
complement c1 inactivator proteins - deficiency (54) 54
complement c4 - metabolism (53) 53
abridged index medicus (52) 52
complement (52) 52
bradykinin - analogs & derivatives (49) 49
deficiency (49) 49
diagnosis, differential (49) 49
patients (49) 49
urticaria (49) 49
care and treatment (48) 48
complement c1 inhibitor protein - therapeutic use (48) 48
internal medicine (48) 48
angioedemas, hereditary - genetics (46) 46
treatment outcome (46) 46
c1-inhibitor deficiency (45) 45
pharmacology & pharmacy (45) 45
permeability (44) 44
therapy (44) 44
angioedemas, hereditary - metabolism (43) 43
danazol - therapeutic use (43) 43
proteins (42) 42
risk factors (42) 42
factor xii - metabolism (41) 41
factor-xii (40) 40
plasma kallikrein (40) 40
angioedemas, hereditary - blood (39) 39
angioedemas, hereditary - physiopathology (39) 39
bradykinin - therapeutic use (38) 38
inflammation (38) 38
kallikreins - metabolism (38) 38
hematology (37) 37
icatibant (37) 37
medicine & public health (37) 37
vascular-permeability (37) 37
dermatology (36) 36
genetic aspects (36) 36
pedigree (36) 36
c1 esterase inhibitor (35) 35
complement activation (35) 35
factor xii - genetics (35) 35
analysis (34) 34
complement system proteins - metabolism (34) 34
danazol (34) 34
hageman-factor (34) 34
medicine, research & experimental (34) 34
pregnancy (34) 34
research (34) 34
disease (33) 33
retrospective studies (33) 33
ace inhibitors (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (717) 717
French (15) 15
German (11) 11
Chinese (3) 3
Polish (3) 3
Danish (2) 2
Japanese (2) 2
Spanish (2) 2
Finnish (1) 1
Hungarian (1) 1
Italian (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 138, Issue 5, pp. 1414 - 1423.e9
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 08/2015, Volume 125, Issue 8, pp. 3132 - 3146
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 09/2018, Volume 16, Issue 9, pp. 1674 - 1685
Summary The plasma contact system contributes to thrombosis in experimental models. Even though our standard blood coagulation tests are prolonged when plasma... 
bradykinin | hereditary angioedema | plasma kallikrein | factor XII | plasmin | TISSUE-PLASMINOGEN ACTIVATOR | MOLECULAR-WEIGHT KININOGEN | CHAIN FACTOR-XII | OROLINGUAL ANGIOEDEMA | CLINICAL CHARACTERISTICS | ACQUIRED C1-INHIBITOR DEFICIENCY | factorXII | VASCULAR-PERMEABILITY | POLYPHOSPHATE NANOPARTICLES | HAGEMAN-FACTOR | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | NORMAL C1 INHIBITOR | Angioedemas, Hereditary - etiology | Capillary Permeability | Complement Activation | Complement C1 Inhibitor Protein - physiology | Kallikreins - physiology | Humans | Male | Hereditary Angioedema Types I and II - blood | Hereditary Angioedema Types I and II - enzymology | Female | Angioedemas, Hereditary - blood | Angioedemas, Hereditary - physiopathology | Serine Proteinase Inhibitors - physiology | Bradykinin - biosynthesis | Kallidin - metabolism | Hereditary Angioedema Types I and II - physiopathology | Inflammation | Kininogen, High-Molecular-Weight - metabolism | Polyphosphates - metabolism | Serine Proteinase Inhibitors - deficiency | Bradykinin - physiology | Factor XIIa - physiology | Phenotype | Models, Biological | Age of Onset | Blood Coagulation - physiology | Angioedemas, Hereditary - enzymology | Enzymes | Angioneurotic edema | Medical examination | Analysis | Bradykinin | Kallikrein | Blood | Plasma | Blood coagulation | Phenotypes | Esterase | Hemostasis | Angioedema | Thrombosis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 12, pp. 1131 - 1140
Journal Article